Vascular Pharmacology

Papers
(The H4-Index of Vascular Pharmacology is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Corrigendum to “Elucidating the crosstalk between endothelial-to-mesenchymal transition (EndoMT) and endothelial autophagy in the pathogenesis of atherosclerosis” [Vascular Pharmacology 155 (2024) 107105
Patterns of medication use and potential drug-drug interactions in post-PCI patients: A study from Iran99
Graphical abstract TOC48
Biobanks: The unmet need in heart failure management38
Graphical abstract TOC34
The transfer of gut microbiota/metabolites from children to mice affects cardiometabolic development and induces sex-dimorphism in recipients34
Thromboprophylaxis strategies to improve the prognosis of COVID-1933
Prevalence of antiphospholipid antibodies in COVID-19 patients: A meta-analysis27
Editorial Board23
Animal experimental models of ischemic limbs – A systematic review23
Molecular mechanisms of flavonoids in myocardial ischemia reperfusion injury: Evidence from in-vitro and in-vivo studies23
Therapy and guideline adherence at a multidisciplinary hypertension clinic: A prospective, observational study23
The MEK-ERK-Egr-1 axis and its regulation in cardiovascular disease23
A random shuffle method to expand a narrow dataset: A heart failure cohort example22
Exploiting endothelial functions in bone regenerative medicine21
Optical stimulation of endothelial colony forming cells plated on light-sensitive conjugated polymers induces a TRPV1-mediated increase in intracellular Ca2+ concentration20
Prevention of cardiovascular complications in elderly cancer patients20
Doxorubicin-induced cardiotoxicity enhance SARS-CoV-2 infection susceptibility in human cardiomyocytes20
Editorial Board19
Editorial Board19
0.039350986480713